| Ascend Counseling, Llc | |
|
700 S 8th Ave Brandon SD 57005-1772 | |
| (507) 829-5592 | |
| Not Available |
| Full Name | Ascend Counseling, Llc |
|---|---|
| Speciality | Social Worker |
| Location | 700 S 8th Ave, Brandon, South Dakota |
| Authorized Official Name and Position | Sarah Shoffner (OWNER) |
| Authorized Official Contact | 5078295592 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Ascend Counseling, Llc 112 W River Oak Ct Brandon SD 57005-2140 Ph: (507) 829-5592 | Ascend Counseling, Llc 700 S 8th Ave Brandon SD 57005-1772 Ph: (507) 829-5592 |
| NPI Number | 1023602703 |
|---|---|
| Provider Enumeration Date | 02/24/2021 |
| Last Update Date | 02/24/2021 |
| Certification Date | 02/24/2021 |
| Medicare PECOS PAC ID | 7719394881 |
|---|---|
| Medicare Enrollment ID | O20210408000501 |
News Archive
New research into the fight against Dengue, an insect-borne tropical disease that infects up to 390 million people worldwide annually, may influence the development of anti-viral therapies that are effective against all four types of the virus.
A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.
NiTi™ Surgical Solutions, an innovative surgical device company, today announced that it will showcase its new, investigational bowel anastomosis device this week at the American College of Surgeons (ACS) 95th Annual Clinical Congress in Chicago, Illinois. The device, which will be marketed as BowelRing™, represents the company's next advancement in its innovative BioDynamix™ Anastomosis Technology platform.
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023602703 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Sarah J Shoffner |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1932623527 PECOS PAC ID: 6305175415 Enrollment ID: I20190913001966 |
News Archive
New research into the fight against Dengue, an insect-borne tropical disease that infects up to 390 million people worldwide annually, may influence the development of anti-viral therapies that are effective against all four types of the virus.
A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.
NiTi™ Surgical Solutions, an innovative surgical device company, today announced that it will showcase its new, investigational bowel anastomosis device this week at the American College of Surgeons (ACS) 95th Annual Clinical Congress in Chicago, Illinois. The device, which will be marketed as BowelRing™, represents the company's next advancement in its innovative BioDynamix™ Anastomosis Technology platform.
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
› Verified 1 days ago
News Archive
New research into the fight against Dengue, an insect-borne tropical disease that infects up to 390 million people worldwide annually, may influence the development of anti-viral therapies that are effective against all four types of the virus.
A novel approach developed by researchers from the University of Leicester and the MRC Toxicology Unit could help to predict how well patients respond to drugs designed to fight various forms of cancer.
NiTi™ Surgical Solutions, an innovative surgical device company, today announced that it will showcase its new, investigational bowel anastomosis device this week at the American College of Surgeons (ACS) 95th Annual Clinical Congress in Chicago, Illinois. The device, which will be marketed as BowelRing™, represents the company's next advancement in its innovative BioDynamix™ Anastomosis Technology platform.
Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced the commencement of a first-in-human study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV). CMX157 has the potential to increase efficacy and decrease toxicity as compared to tenofovir, and may enable the creation of new 'one pill, once-a-day', fixed-dose combination regimens for the treatment of HIV infection.
› Verified 1 days ago
Br Counseling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 400 S 1st Ave, Brandon, SD 57005 Phone: 605-360-0194 | |
Embrace Play, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 700 S 8th Ave, Brandon, SD 57005 Phone: 605-582-4722 | |
G&b Properties Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 700 S 8th Ave, Brandon, SD 57005 Phone: 605-582-4722 | |
Aspire Counseling & Consulting, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1320 E Rushmore Dr, 107, Brandon, SD 57005 Phone: 605-310-4471 | |
New Day Counseling Services, Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1320 E Rushmore Dr Ste 107, Brandon, SD 57005 Phone: 605-582-7418 Fax: 605-582-7419 | |
Mindful Wellness, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 700 S 8th Ave, Brandon, SD 57005 Phone: 605-582-3197 Fax: 605-582-3197 |